Miles W. Carroll
Researcher Next ID · RN-023498
Researcher · Medicine
Oxford, Poland
- Works count
- 376
- Citation count
- 39,922
- H-index
- 85
- i10-index
- 239
Research interests
Publications
SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
Cell · 2022 · https://doi.org/10.1016/j.cell.2021.12.046
Antibody evasion by the P.1 strain of SARS-CoV-2
Cell · 2021 · https://doi.org/10.1016/j.cell.2021.03.055
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera
Cell · 2021 · https://doi.org/10.1016/j.cell.2021.02.037
Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum
Cell · 2021 · https://doi.org/10.1016/j.cell.2021.06.020
The antigenic anatomy of SARS-CoV-2 receptor binding domain
Cell · 2021 · https://doi.org/10.1016/j.cell.2021.02.032
Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern
Nature Communications · 2021 · https://doi.org/10.1038/s41467-021-25167-5
Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine
Cell · 2021 · https://doi.org/10.1016/j.cell.2021.10.011
Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera
Cell · 2021 · https://doi.org/10.1016/j.cell.2021.02.033
Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
Nature Medicine · 2020 · https://doi.org/10.1038/s41591-020-01179-4
Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
Nature Medicine · 2020 · https://doi.org/10.1038/s41591-020-01179-4
Antibody testing for COVID-19: A report from the National COVID Scientific Advisory Panel
Wellcome Open Research · 2020 · https://doi.org/10.12688/wellcomeopenres.15927.1
Animal models for COVID-19
Nature · 2020 · https://doi.org/10.1038/s41586-020-2787-6
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
The Lancet · 2020 · https://doi.org/10.1016/s0140-6736(20)31604-4
Genomic and epidemiological monitoring of yellow fever virus transmission potential
Science · 2018 · https://doi.org/10.1126/science.aat7115
Multiplex PCR method for MinION and Illumina sequencing of Zika and other virus genomes directly from clinical samples
Nature Protocols · 2017 · https://doi.org/10.1038/nprot.2017.066
Virus genomes reveal factors that spread and sustained the Ebola epidemic
Nature · 2017 · https://doi.org/10.1038/nature22040
Rapid outbreak sequencing of Ebola virus in Sierra Leone identifies transmission chains linked to sporadic cases
Virus Evolution · 2016 · https://doi.org/10.1093/ve/vew016
Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)
The Lancet · 2016 · https://doi.org/10.1016/s0140-6736(16)32621-6
Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial
The Lancet · 2015 · https://doi.org/10.1016/s0140-6736(15)61117-5
Temporal and spatial analysis of the 2014–2015 Ebola virus outbreak in West Africa
Nature · 2015 · https://doi.org/10.1038/nature14594
Current projects
No projects listed.